Targeting of CD163+ Macrophages in Inflammatory and Malignant Diseases

MK Skytthe, JH Graversen, SK Moestrup - International journal of …, 2020 - mdpi.com
The macrophage is a key cell in the pro-and anti-inflammatory response including that of the
inflammatory microenvironment of malignant tumors. Much current drug development in …

Role of omentin, vaspin, cardiotrophin-1, TWEAK and NOV/CCN3 in obesity and diabetes development

X Escoté, S Gómez-Zorita, M López-Yoldi… - International journal of …, 2017 - mdpi.com
Adipose tissue releases bioactive mediators called adipokines. This review focuses on the
effects of omentin, vaspin, cardiotrophin-1, Tumor necrosis factor-like Weak Inducer of …

The haptoglobin‐CD163‐heme oxygenase‐1 pathway for hemoglobin scavenging

JH Thomsen, A Etzerodt, P Svendsen… - … medicine and cellular …, 2013 - Wiley Online Library
The haptoglobin‐(Hp‐) CD163‐heme oxygenase‐1 (HO‐1) pathway is an efficient captor‐
receptor‐enzyme system to circumvent the hemoglobin (Hb)/heme‐induced toxicity during …

The TWEAK/Fn14/CD163 axis—implications for metabolic disease

W Ratajczak, SD Atkinson, C Kelly - Reviews in Endocrine and Metabolic …, 2022 - Springer
TWEAK (tumor necrosis factor-like weak inducer of apoptosis) is a member of the TNF
superfamily that controls a multitude of cellular events including proliferation, migration …

Clinical significance of sCD163 and its possible role in asthma

Y Zhi, P Gao, X Xin, W Li, L Ji… - Molecular …, 2017 - spandidos-publications.com
Macrophages exert important functions in the balance and efficiency of immune responses,
and participate in innate and adaptive immunity. The proinflammatory actions of …

TRAIL, OPG, and TWEAK in kidney disease: biomarkers or therapeutic targets?

S Bernardi, R Voltan, E Rimondi, E Melloni… - Clinical …, 2019 - portlandpress.com
Ligands and receptors of the tumor necrosis factor (TNF) superfamily regulate immune
responses and homeostatic functions with potential diagnostic and therapeutic implications …

TWEAK: a new player in obesity and diabetes

J Vendrell, MR Chacón - Frontiers in immunology, 2013 - frontiersin.org
Obesity and type 2 diabetes (T2D) are associated with chronic low-grade inflammation.
Mounting evidence suggests the involvement of an inflammatory switch in adipose tissue …

The effects of resveratrol supplementation on PPARα, p16, p53, p21 gene expressions, and sCD163/sTWEAK ratio in patients with type 2 diabetes mellitus: A …

O Toupchian, S Abdollahi… - Phytotherapy …, 2021 - Wiley Online Library
The present study sought to evaluate the effect of resveratrol supplementation on mRNA
expression levels of peroxisome proliferator‐activated receptor alpha (PPARα), p53, p21 …

Is TWEAK a biomarker for autoimmune/chronic inflammatory diseases?

D Bertin, D Stephan, M Khrestchatisky… - Frontiers in …, 2013 - frontiersin.org
The TWEAK/Fn14 pathway is now well-known for its involvement in the modulation of
inflammation in various human autoimmune/chronic inflammatory diseases (AICID) …

The rise of soluble TWEAK levels in severely obese subjects after bariatric surgery may affect adipocyte-cytokine production induced by TNFα

E Maymó-Masip, S Fernández-Veledo… - The Journal of …, 2013 - academic.oup.com
Context: Soluble TNF-like weak inducer of apoptosis (sTWEAK) is generated by the
intracellular proteolytic cleavage of full-length membrane-bound TNF-like weak inducer of …